Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Ewing × Dactinomycin × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Rhabdomyosarcoma, Embryonal 2 Rhabdomyosarcoma 2 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Sarcoma, Ewing 1 Rhabdomyosarcoma, Alveolar 1 Pleuropulmonary blastoma 1

Interventions

Temozolomide 7 Vincristine 5 Irinotecan 5 Cyclophosphamide 4 Etoposide 3 etoposide phosphate 2 cabozantinib 2 abemaciclib 2 Ifosfamide 2 Doxorubicin 2 silmitasertib 1 romiplostim 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 liposomal doxorubicin 1 ganitumab 1 fludarabine 1 dinutuximab 1 Zoledronic Acid 1 X-Rays 1 Whole-Body Irradiation 1 Weight-Bearing 1 Topotecan 1 Tacrolimus 1 Specimen Handling 1 Sirolimus 1 Range of Motion, Articular 1 Radiotherapy, Image-Guided 1 Radiosurgery 1 Radiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07194044 2026-03-16

METTSEO

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Recruiting

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡